EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Malondialdehyde Serum Levels in a Full Characterized Series of 430 Rheumatoid Arthritis Patients

Nayra Merino de Paz, Juan Carlos Quevedo-Abeledo iD, Fuensanta Gómez-Bernal, Antonia de Vera-González, Pedro Abreu-González, Candelaria Martín-González iD, Miguel Ángel González-Gay, Iván Ferraz-Amaro iD

Journal of Clinical Medicine · 04.02.2024 · 13 (3) · 901

DOI: 10.3390/jcm13030901 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 04.02.2024. Verfasst von Nayra Merino de Paz und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Dermatology, Dermamedicin Clínicas, 38004 Santa Cruz de Tenerife, Spain. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Instituto de Salud Carlos III, Fundación Canaria Instituto de Investigación Sanitaria de Canarias (FIISC).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Oxidative stress has been involved in the pathogenesis of rheumatoid arthritis (RA). The serum malondialdehyde (MDA) level is a reliable biomarker of oxidative stress status. In the present work, we aimed to analyze how a comprehensive characterization of the disease characteristics in RA, including a lipid profile, insulin resistance, and subclinical atherosclerosis, relates to serum MDA levels.

Methods

In a cross-sectional study that included 430 RA patients, serum MDA levels were evaluated. Multivariable analysis was performed to examine the relationship of MDA with disease activity scores and disease characteristics, including subclinical carotid atherosclerosis, a comprehensive lipid molecule profile, and indices of insulin resistance and beta cell function indices.

Results

The erythrocyte sedimentation rate (ESR) showed a significant and positive relationship with MDA. However, this did not occur for other acute phase reactants such as C-reactive protein or interleukin-6. Although the DAS28-ESR score (Disease Activity Score in 28 joints) had a positive and significant association with MDA serum levels, other disease activity scores that do not use the erythrocyte sedimentation rate in their formula did not show a significant relationship with MDA. Other disease characteristics, such as disease duration and the existence of rheumatoid factor and antibodies against citrullinated protein, were not related to serum MDA levels. This also occurred for lipid profiles, insulin resistance indices, and subclinical carotid atherosclerosis, for which no associations with circulating MDA were found.

Conclusions

The disease characteristics are not related to circulating MDA levels in patients with RA.

Schlagwörter

Stichwörter der Autor:innen

disease activitymalondialdehyde serum levelsrheumatoid arthritis

Autor:innen und Institutionen

  • Division of Dermatology, Dermamedicin Clínicas, 38004 Santa Cruz de Tenerife, Spain.
  • Division of Rheumatology, Hospital Universitario Dr. Negrín, 35010 Las Palmas de Gran Canaria, Spain.
  • Division of Central Laboratory, Hospital Universitario de Canarias, 38320 Tenerife, Spain.
  • Unit of Physiology, Department of Basic Medical Sciences, University of La Laguna, 38200 Tenerife, Spain.
  • Internal Medicine Department, Universidad de La Laguna, 38200 Tenerife, Spain.
  • Department of Medicine, University of Cantabria, 39005 Santander, Spain.

ORCID-Profile: Juan Carlos Quevedo-Abeledo, Candelaria Martín-González, Iván Ferraz-Amaro

Förderung

  • Instituto de Salud Carlos III
  • Fundación Canaria Instituto de Investigación Sanitaria de Canarias (FIISC)

Zitieren

APA

Merino de Paz, N., Quevedo-Abeledo, J. C., Gómez-Bernal, F., de Vera-González, A., Abreu-González, P., Martín-González, C., González-Gay, M. Á., & Ferraz-Amaro, I. (2024). Malondialdehyde Serum Levels in a Full Characterized Series of 430 Rheumatoid Arthritis Patients. Journal of Clinical Medicine, 13(3), 901. https://doi.org/10.3390/jcm13030901

Vancouver

Merino de Paz N, Quevedo-Abeledo JC, Gómez-Bernal F, de Vera-González A, Abreu-González P, Martín-González C, et al. Malondialdehyde Serum Levels in a Full Characterized Series of 430 Rheumatoid Arthritis Patients. Journal of Clinical Medicine. 2024;13(3):901. doi:10.3390/jcm13030901

BibTeX
@article{MerinodePaz2024,
  author = {Merino de Paz, Nayra and Quevedo-Abeledo, Juan Carlos and Gómez-Bernal, Fuensanta and de Vera-González, Antonia and Abreu-González, Pedro and Martín-González, Candelaria and González-Gay, Miguel Ángel and Ferraz-Amaro, Iván},
  title = {Malondialdehyde Serum Levels in a Full Characterized Series of 430 Rheumatoid Arthritis Patients},
  journal = {Journal of Clinical Medicine},
  year = {2024},
  volume = {13},
  number = {3},
  pages = {901},
  doi = {10.3390/jcm13030901}
}
Kostenlos starten →